Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
EGFR
More Information »The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase of the ErbB family. Four members of the ErbB family have been identified; EGFR (ErbB1, HER1), ErbB2 (HER2), ErbB3 (HER3) and ErbB4 (HER4). EGFR signaling drives many cellular responses.
EGFR Products
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 1276 | AG 1478 hydrochloride |
| Highly potent EGFR-kinase inhibitor | |
| 0493 | AG 18 |
| EGFR/PDGFR-kinase inhibitor | |
| 0414 | AG 490 |
| EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor | |
| 0619 | AG 494 |
| Potent EGFR-kinase inhibitor | |
| 0618 | AG 555 |
| Potent EGFR-kinase inhibitor | |
| 0616 | AG 556 |
| EGFR-kinase inhibitor | |
| 1555 | AG 825 |
| Selective ErbB2 inhibitor | |
| 2617 | AG 879 |
| ErbB2 inhibitor | |
| 0497 | AG 99 |
| EGFR-kinase inhibitor | |
| 2417 | BIBU 1361 dihydrochloride |
| Selective inhibitor of EGFR-kinase | |
| 2416 | BIBX 1382 dihydrochloride |
| Highly selective EGFR-kinase inhibitor | |
| 3360 | CGP 52411 |
| EGFR inhibitor. Also inhibits Aβ42 fibril formation | |
| 1110 | Genistein |
| EGFR kinase inhibitor. Also estrogen and PPARγ ligand | |
| 2239 | GW 583340 dihydrochloride |
| Potent dual EGFR/ErbB2 inhibitor; orally active | |
| 2646 | HDS 029 |
| Potent inhibitor of the ErbB receptor family | |
| 3000 | Iressa |
| Orally active, selective EGFR inhibitor | |
| 3352 | JNJ 28871063 hydrochloride |
| Potent ErbB receptor family inhibitor | |
| 1331 | Lavendustin A |
| EGFR, p60c-src inhibitor | |
| 0577 | Methyl 2,5-dihydroxycinnamate |
| EGFR-kinase inhibitor | |
| 1037 | PD 153035 hydrochloride |
| EGFR-kinase inhibitor | |
| 2615 | PD 158780 |
| Potent ErbB receptor family inhibitor | |
| 2794 | PP 3 |
| EGFR-kinase inhibitor. Also Src kinase negative control | |
| 3599 | TAK 165 |
| Potent and selective ErbB2 inhibitor | |
| 0578 | Tyrphostin B44, (-) enantiomer |
| EGFR-kinase inhibitor | |
| 0579 | Tyrphostin B44, (+) enantiomer |
| EGFR-kinase inhibitor | |
| 3115 | WHI-P 154 |
| Potent EGFR inhibitor. Also inhibits JAK3 | |
Related Categories
Quick Order
Find multiple products by catalog number
Cancer Research Guide
Request your free copy
Highlights over 350 products for cancer research. Request a copy or view PDF today.
Kinases Product Listing
Highlights over 350 products for kinase research. Request a copy or view PDF today.
Kinase Inhibitor Toolbox
80 Kinase inhibitors
pre-dissolved in DMSO
Some of the most potent
kinase inhibitors all on one plate
Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.
VEGF Pathway & Anti-Angiogenic Therapy
Written by N. Ferrara & Y. Crawford
A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.
Therapeutic Strategies in Schizophrenia
Written by J. Lieberman
'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.
Twitter Updates
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.